NeuroQore is a pioneering brand dedicated to developing groundbreaking neuromodulation treatments for various neurobehavioral conditions. Comprised of a passionate team of scientists, engineers, and clinicians, NeuroQore collaborates with world-class universities and research clinics to investigate ways to transform lives. Our mission is to create effective solutions for devastating disorders such as major depressive disorder and suicidality.

Despite the staggering prevalence of treatment-resistant depression (TRD) and acute suicidality, current standard treatments like repetitive transcranial magnetic stimulation (rTMS) and electroconvulsive therapy (ECT) are inefficient and outdated. ECT, while potentially effective, has a delayed onset of effect and is met with debilitating side effects and social stigma. NeuroQore recognizes the critical importance of addressing this gap in the healthcare system and is committed to investigating new innovative approaches.

We believe that a new treatment for TRD and acute suicidality is a priority. If you are seeking effective solutions for neurobehavioral conditions, please reach out to us at info@neuroqore. com.

Together, let's make a difference and transform lives